During growth on one-carbon (C 1 ) compounds, the aerobic ␣-proteobacterium Methylobacterium extorquens AM1 synthesizes the tetrahydromethanopterin (H 4 MPT) derivative dephospho-H 4 MPT as a C 1 carrier in addition to tetrahydrofolate. The enzymes involved in dephospho-H 4 MPT biosynthesis have not been identified in bacteria. In archaea, the final step in the proposed pathway of H 4 MPT biosynthesis is the reduction of dihydromethanopterin (H 2 MPT) to H 4 MPT, a reaction analogous to the reaction of the bacterial dihydrofolate reductase. A gene encoding a dihydrofolate reductase homolog has previously been reported for M. extorquens and assigned as the putative H 2 MPT reductase gene (dmrA). In the present work, we describe the biochemical characterization of H 2 MPT reductase (DmrA), which is encoded by dmrA. The gene was expressed with a six-histidine tag in Escherichia coli, and the recombinant protein was purified by nickel affinity chromatography and gel filtration. Purified DmrA catalyzed the NAD(P)H-dependent reduction of H 2 MPT with a specific activity of 2.8 mol of NADPH oxidized per min per mg of protein at 30°C and pH 5.3. Dihydrofolate was not a substrate for DmrA at the physiological pH of 6.8. While the existence of an H 2 MPT reductase has been proposed previously, this is the first biochemical evidence for such an enzyme in any organism, including archaea. Curiously, no DmrA homologs have been identified in the genomes of known methanogenic archaea, suggesting that bacteria and archaea produce two evolutionarily distinct forms of dihydromethanopterin reductase. This may be a consequence of different electron donors, NAD(P)H versus reduced F 420 , used, respectively, in bacteria and methanogenic archaea.
The aerobic ␣-proteobacterium Methylobacterium extorquens AM1 is capable of growth on one-carbon (C 1 ) and selected multicarbon compounds. During the catabolism of C 1 compounds, M. extorquens synthesizes an analog of the coenzyme tetrahydromethanopterin (H 4 MPT) called dephospho-H 4 MPT ( Fig. 1 ) in addition to tetrahydrofolate (H 4 F) (7) . Although H 4 MPT was initially identified as a C 1 carrier in methanogenic archaea (10, 19) , analogs of H 4 MPT and H 4 MPT-dependent enzymes have been identified in sulfur-dependent hyperthermophilic archaea and methylotrophic proteobacteria (7, 13, 21, 24, 37, 39, 40) . While H 4 F and H 4 MPT possess common structural features, they differ in other structural respects, and they play distinct functional roles (22) . In particular, in M. extorquens, H 4 F appears to be primarily involved in carbon assimilation and anabolism, while dephospho-H 4 MPT is required for the catabolism of C 1 growth substrates (6, 7) . In M. extorquens, the genes encoding a number of dephospho-H 4 MPT-dependent enzymes are clustered together in a DNA region required for growth on C 1 compounds (7) . Several of these bacterial enzymes are homologous to archaeal enzymes involved in C 1 metabolism during methanogenesis (7, 26, 27, 28) .
The pathway for the biosynthesis of dephospho-H 4 MPT in M. extorquens and other bacteria is not known. However, an 18-step pathway for H 4 MPT biosynthesis in methanogenic archaea has been proposed (41) . Thus far, 4 of the 18 putative H 4 MPT biosynthetic enzymes and their corresponding genes have been identified (15, 16, 31, 44) . Interestingly, in M. extorquens a gene encoding a homolog of a key H 4 MPT biosynthetic enzyme, ribofuranosylaminobenzene 5Ј-phosphate synthase, has been found within the cluster of genes coding for H 4 MPT-dependent enzymes (7, 31) . Therefore, it is likely that the biosynthesis of H 4 MPT analogs in archaea and bacteria share some common enzymatic steps.
The last step in the proposed pathway of H 4 MPT biosynthesis in archaea is the reduction of dihydromethanopterin (H 2 MPT) to H 4 MPT, catalyzed by a putative H 2 MPT reductase ( Fig. 1) (41) . This step is analogous to the well-characterized reaction of bacterial dihydrofolate (H 2 F) reductases (DHFRs) in H 4 F biosynthesis (4). Marx et al. (23) have recently discovered a gene in M. extorquens (the dmrA gene) that codes for a DHFR homolog. Deletion of this gene produces a mutant that is highly sensitive to methanol and formaldehyde toxicity and is deficient in the ability to grow on C 1 compounds. These properties are consistent with the phenotype of a mutant deficient in dephospho-H 4 MPT-dependent metabolism (17, 38) . Using an enzymatic assay that detects dephospho-H 4 MPT as well as H 4 MPT in cell extracts, our laboratory has determined that the dmrA mutant is incapable of producing dephospho-H 4 MPT, suggesting a defect in the pathway of dephospho-H 4 MPT biosynthesis (S. A. Wyles and M. E. Rasche, unpublished results). Based on the sequence similarity of the DmrA protein to DHFR and the inability of dmrA mutants to produce dephospho-H 4 MPT, it has been proposed that the dmrA gene codes for the putative H 2 MPT reductase (DmrA) (23) . In the present work, we have tested this hypothesis directly by expressing dmrA with a six-histidine tag in Escherichia coli and developing an assay to measure H 2 MPT reductase activity in vitro. This is the first biochemical characterization of a H 2 MPT reductase from any microorganism.
MATERIALS AND METHODS
Heterologous expression of dmrA in E. coli. The 405-bp dmrA gene from M. extorquens encodes a protein with a predicted molecular mass of 17 kDa (23) . A plasmid containing the dmrA gene in the pCR 2.1 vector (Invitrogen, Carlsbad, Calif.) was kindly provided by Christopher Marx and Mary Lidstrom. The dmrA gene was subcloned into the NdeI and BamHI sites of the pET15b(ϩ) expression vector (Novagen, Inc., Madison Wis.), which incorporates an N-terminal sixhistidine (His 6 ) tag during production of the recombinant protein. Since the dmrA gene contains an internal BamHI site, the pCR2.1 plasmid containing dmrA was cut with NdeI and BglII, producing a cohesive end that was compatible with BamHI. The vector pET15b(ϩ) was digested with NdeI and BamHI, and the DNA fragments were separated on a 0.8% agarose gel. The appropriate pET15b and dmrA fragments were excised from the gel, purified using a gel extraction kit (Qiagen, Valencia, Calif.), and ligated with T4 DNA ligase (New England Biolabs, Beverly, Mass.). The new plasmid (pMC26) was transformed into electrocompetent E. coli DH5␣ cells (30) .
For production of the His 6 -DmrA protein, pMC26 was transformed into chemically competent BL21(DE3) cells (Stratagene, La Jolla, Calif.). The cells were grown at 37°C with shaking (200 rpm) in 1 liter of M9 minimal medium (30) supplemented with glucose (final concentration, 0.4%) and ampicillin (125 g/ ml). When the optical density at 600 nm reached 0.4 to 0.5, the temperature was lowered to 15°C for 45 min. Subsequently, gene expression was induced with the addition of isopropyl thio-␤-D-galactoside (Inalco Pharmaceuticals, San Luis Obispo, Calif.) to a concentration of 1 mM. The cells were grown at 15°C for 16 h, harvested by centrifugation (5,000 ϫ g, 15 min, 4°C), and frozen at Ϫ20°C.
Purification of His 6 -DmrA. The His 6 -DmrA protein was purified aerobically using nickel affinity chromatography and gel filtration. Cells (4 g) were suspended in 8 ml of lysis buffer (50 mM sodium phosphate, 300 mM sodium chloride, 15 mM 2-mercaptoethanol, 20 mM imidazole [pH 8.0]) and disrupted using a French press at 20,000 lb/in 2 . The mixture was centrifuged at 27,000 ϫ g for 30 min at 4°C, and the supernatant was filtered through a 0.45-m-pore-size filter (Millipore, Bedford, Mass.). To the resulting filtrate (8 ml), 2 ml of 50% nickel-nitrilotriacetic acid (Ni-NTA) agarose (Qiagen, Valencia, Calif.) was added. The mixture was placed on a rocking shaker for 2 h at 4°C and poured into an empty 10-ml column (Bio-Rad, Hercules, Calif.). The Ni-NTA agarose was then washed three times with 5 ml of lysis buffer containing 30 mM imidazole, pH 8.0. The desired protein was eluted with 4 ml of elution buffer (50 mM sodium phosphate, 300 mM sodium chloride, 15 mM 2-mercaptoethanol, 100 mM imidazole [pH 8.0]). DmrA partially purified by Ni-NTA agarose was stable for 3 to 4 days at 4°C and for at least 3 months at Ϫ20°C when stored in the presence of 25% (vol/vol) glycerol.
For gel filtration analysis, the 4-ml fraction containing His 6 -DmrA was concentrated to 100 l with a Centricon microconcentrator (3,000-molecular-weight cutoff; Millipore), and the retentate was diluted to 325 l with 50 mM N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (pH 7.0), 10 mM MgCl 2 , 150 mM KCl, and 2 mM dithiothreitol. A portion of the sample (250 l) was applied to a Superdex 75 gel filtration column (Amersham-Pharmacia Biotech, Piscataway, N.J.) equilibrated with the same buffer. The His 6 -DmrA protein was eluted between 11 and 12 ml, corresponding to an apparent molecular mass of 38.5 kDa. The molecular mass markers were bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsin (25 kDa), and RNase A (13.7 kDa) (Amersham-Pharmacia Biotech). His 6 -DmrA that was purified to homogeneity by Ni-NTA chromatography and gel filtration was stable at 4°C under anaerobic conditions for 24 h; however, the highly purified enzyme was not stable to freezing at Ϫ20°C under the conditions tested.
Protein purity was determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (12) with Coomassie brilliant blue R-250 as the stain (Bio-Rad, Hercules, Calif.). Protein concentrations were determined using the protein dye binding assay (5) (Bio-Rad) with bovine serum albumin as the standard.
Preparation of H 2 MPT and dihydrosarcinapterin (H 2 SPT) from methanogen cell extracts. Cells of the methanogens Methanothermobacter thermautotrophicus ⌬H (formerly Methanobacterium thermoautotrophicum ⌬H) (provided by Ralph Wolfe) and Methanosarcina thermophila TM-1 (31) were used as sources of H 2 MPT and H 2 SPT, respectively. Purification steps were performed in an anaerobic chamber (Coy Products, Inc., Grass Lake, Mich.) containing 2% hydrogen and 98% nitrogen, and samples were protected from light to avoid inactivation of the light-sensitive coenzyme. M. thermophila cells were grown as described previously (31) and frozen in liquid nitrogen. Frozen cells (5 g) were purged with H 2 gas for 5 min in a sealed 37-ml glass vial and thawed in the presence of hydrogen to enzymatically reduce oxidized pterins to the fully reduced forms (H 4 MPT and tetrahydrosarcinapterin [H 4 SPT]). Anoxic buffer (10 ml of 30 mM sodium acetate [pH 4.0], 200 mM 2-mercaptoethanol) was added, and the vial was wrapped in foil and autoclaved for 15 min. After cooling, the mixture was centrifuged at 13,000 ϫ g for 20 min at 25°C in the anaerobic chamber to remove precipitated proteins. The supernatant (8 ml) containing H 4 MPT or H 4 SPT was mixed with 8 ml of buffer A (50 mM morpholinepropanesulfonic acid [pH 6.8], 150 mM 2-mercaptoethanol) and applied to a 2-ml DEAE Sephadex A-25 column (Amersham-Pharmacia Biotech) wrapped in foil. The column was washed with buffer A, and coenzymes were eluted with a 0 to 1.5 M NaCl gradient in buffer A. H 4 MPT from M. thermautotrophicus ⌬H was eluted at 200 mM NaCl, and H 4 SPT from M. thermophila was eluted at 500 mM NaCl. H 4 MPT and H 4 SPT were partially oxidized by incubating the fractions aerobically at 4°C in the dark for 14 h. Air oxidation of H 4 MPT or H 4 SPT produced a mixture containing the dihydro and tetrahydro forms of the coenzyme, as indicated by changes in the absorbance spectrum between 200 and 400 nm (10) . The characteristic 302-nm absorbance of the tetrahydropterins decreased gradually upon exposure to air, and a 280-nm peak increased, indicative of the more oxidized form.
DmrA assay. An enzymatic assay for DmrA ( Fig. 1) was developed, based on modifications of the DHFR assay (1, 18, 32) . All procedures were conducted in an anaerobic chamber or in sealed 3-ml glass cuvettes. The standard reaction mixture (1.8 ml) consisted of 36 g of His 6 -DmrA and an anoxic solution containing 500 mM sodium acetate (pH 5.3), 20 mM sodium ascorbate, and 1 mM EDTA. To this solution, 200 l of the DEAE-Sephadex fractions containing either H 2 MPT or H 2 SPT was added, and the cuvette was incubated for 20 min at 30°C in the absence of light. The reaction was initiated with 20 l of 10 mM We also made attempts to measure the product H 4 SPT by using reverse-phase high-pressure liquid chromatography (HPLC); however, we were unable to resolve H 2 SPT and H 4 SPT by HPLC using a variety of different conditions. In addition, H 2 SPT and H 4 SPT could not be quantified spectrally at 280 and 302 nm because of interference from the absorbance due to ascorbate, NADPH, and NADP ϩ in the assay. Thus, for this initial characterization of DmrA, NADPH oxidation in the presence of H 2 SPT or H 2 MPT was monitored using a procedure based on the DHFR assay (18) .
The effect of temperature on enzyme activity was measured between 20 and 50°C. The pH optimum was determined using an anoxic mixed buffer containing 100 mM sodium acetate, 100 mM morpholineethanesulfonic acid, and 100 mM bistrispropane, over a pH range from 4.3 to 7.8. To test whether reduced methyl viologen serves as an electron donor for the DmrA reaction, NADPH was replaced with 5 mM reduced methyl viologen. The methyl viologen solution was initially reduced with dithionite to produce an absorbance at 578 nm of 0.6.
Chemicals and enzymes. Restriction enzymes and ligase were purchased from New England Biolabs (Beverly, Mass.). NADPH, NADH, methyl viologen, bistrispropane, and H 2 F were from Sigma Chemical Corp. (St. Louis, Mo.). Gases were obtained from Strate Welding (Gainesville, Fla.). All other chemicals were of reagent grade and were purchased from Fisher Scientific (Suwanee, Ga.).
RESULTS
Amino acid sequence comparisons. Amino acid sequence alignments showed that the proteins with the highest level of similarity to the putative H 2 MPT reductase (DmrA) from M. extorquens AM1 were DHFRs from M. extorquens (34% identity, 53% similarity), Vibrio cholerae (31% identity, 44% similarity), and Lactobacillus casei (26% identity, 44% similarity) (23, 36) . While the overall identity among the proteins was relatively low, a careful comparison of the DmrA sequence to the L. casei DHFR sequence showed that 14 of the 18 amino acids important for NADPH binding in DHFR from L. casei (3, 11, 23) were identical or highly similar to the corresponding amino acids in DmrA. This suggested that NADPH could be the hydride donor for the DmrA reaction. A critical acidic amino acid that is conserved in DHFRs from many organisms was also found in DmrA at position 35. In DHFR, this aspartic acid plays an important role in binding the pterin ring of folate and structurally related inhibitors (4). Interestingly, although H 4 MPT was first characterized in methanogenic archaea, no archaeal homologs of DmrA could be identified using sequence alignments (2) .
Overproduction and purification of the DmrA protein. The sequence similarity of DmrA to DHFRs and the inability of dmrA mutants to synthesize dephospho-H 4 MPT led to the proposal that DmrA functions as a putative H 2 MPT reductase (23) . To test this hypothesis biochemically, we cloned the dmrA gene into an overexpression vector that adds an amino-terminal His 6 tag to DmrA (His 6 -DmrA) during protein synthesis in E. coli. When E. coli cells containing pMC26 were grown at 37°C in Luria-Bertani medium and induced with isopropyl thio-␤-D-galactoside, His 6 -DmrA was produced in an insoluble form as indicated by SDS-PAGE analysis (data not shown). However, when cells were grown in M9 minimal medium with glucose and induced at 15°C, a soluble 17-kDa protein was produced in relatively high amounts (Fig. 2, lane 2) . The 17-kDa His 6 -DmrA protein was purified to homogeneity using nickel affinity chromatography and gel filtration (Fig. 2 , lanes 3 and 4; Table 1 ). The purified enzyme was eluted from the Superdex 75 column with an apparent molecular mass of 38.5 kDa, indicating that the protein is a homodimer.
Enzymatic activity of His 6 -DmrA. To determine whether His 6 -DmrA catalyzes the proposed H 2 MPT reductase reaction, His 6 -DmrA was purified by nickel column chromatography and combined with NADPH plus H 2 MPT from H 2 -treated M. thermautotrophicus ⌬H in an acetate buffer at pH 5.3. Methanogenic archaea were used as a source of dihydropterins because they contain up to 20-fold-higher concentrations of methanopterin than M. extorquens cells (7) . In the absence of His 6 -DmrA, the A 340 decreased gradually (Fig. 3, trace A) due to the nonenzymatic decomposition of NADPH, which is somewhat unstable in acidic solutions (9) . A similar nonenzymatic decrease in the A 340 was reported previously for assays measuring the activity of DHFRs in acidic solutions (18) . In contrast, when His 6 -DmrA was added to the reaction mixture, the A 340 decreased rapidly (Fig. 3 , trace E), providing evidence that His 6 -DmrA catalyzes the NADPH-dependent reduction of H 2 MPT. As a control, heat-inactivated protein was tested for activity in the presence of H 2 MPT; under these conditions, the rate of NADPH oxidation was the same as the background rate (Fig. 3, trace B) . H 2 SPT, the H 2 MPT analog found in methanogens of the genus Methanosarcina, was also a substrate for His 6 -DmrA (Fig. 3, trace D) . In contrast, when preparations of H 2 MPT and H 2 SPT were exposed to air for longer than 24 h at 4°C, activity in the DmrA assay was not detectable (data not shown), suggesting that under the conditions tested, the fully oxidized forms of methanopterin and sarcinapterin were not the principal substrates for DmrA.
The pH optimum for DmrA was determined to be 5.3 ( Fig.  4A) , similar to the pH optima for many DHFRs from vertebrate sources (4) . At pH 5.3, the temperature optimum for DmrA was 30°C (Fig. 4B) , which corresponds to the optimal growth temperature for M. extorquens. The specific activity of the E. coli extract containing His 6 -DmrA was 0.098 U/mg of protein under these optimal enzymatic conditions ( Table 1) . After purification of His 6 -DmrA to homogeneity (Fig. 2, lane  4) , the final specific activity was 2.8 U/mg of protein (Table 1) . This is similar to the rates reported for H 2 F reduction by both bacterial and eukaryal DHFRs (4, 32, 43) .
To test whether H 2 F could be reduced by DmrA, H 2 MPT was replaced with H 2 F at concentrations up to 100 M, which is 10 to 100 times higher than the reported Km values of H 2 F for DHFRs (4, 43) . Under the physiological conditions of growth for M. extorquens (pH 6.8, 30°C) (25) , no H 2 F-dependent NADPH oxidation activity was observed (data not shown). When H 2 F was tested under the conditions optimal for the enzymatic reaction of His 6 -DmrA (pH 5.3, 30°C), NADPH was oxidized at a low rate (0.119 U/mg of protein; Fig. 3, trace C) . This activity was approximately 7% of the specific activity observed in the presence of H 2 MPT.
When NADH was used as the electron donor, the specific activity of DmrA was only 15% of the rate observed with NADPH. A similar preference for NADPH rather than NADH has been observed for DHFRs from both eukaryotes and bacteria (4, 8, 42) . Reduced methyl viologen was examined as a possible electron donor, but it did not serve as a reductant for DmrA under the conditions tested (data not shown).
DISCUSSION
The present work provides biochemical evidence that the enzyme encoded by dmrA from M. extorquens catalyzes the NADPH-dependent reduction of H 2 MPT to H 4 MPT, as postulated by Marx et al. (23) . This is the first H 2 MPT reductase to be characterized from any organism and the first biochemical demonstration of a H 4 MPT biosynthesis enzyme in bacteria. The conservation between the NADPH-binding residues of L. casei DHFR and DmrA (23) provided a clue that the hydride donor for DmrA was NADPH rather than F 420 H 2 , a reductant found in methanogenic archaea (10, 14) . The histidine tag enabled rapid purification of the enzyme to homogeneity ( Fig. 2 and Table 1 ). Purified His 6 -DmrA was a homodimer, which contrasts with the monomeric structure of DHFRs isolated from vertebrates and most bacteria (4). An exception is the thermostable DHFR from Thermotoga maritima, which is also a dimeric enzyme (43) . It remains to be determined if the dimeric nature of His 6 -DmrA is an intrinsic property of the enzyme or a consequence of heterologous expression in E. coli.
The physiological substrate for DmrA is predicted to be the dephospho analog of H 2 MPT. This molecule lacks the hy- The optimum pH for purified DmrA (36 g of protein) was determined by monitoring the decrease in A 340 at 30°C in a mixed buffer, as described in Materials and Methods. The velocity was determined during the initial part of the assay over the time period that the rate was constant. (B) The temperature optimum for DmrA was determined at the optimal pH in buffer containing 100 mM acetate, pH 5.3, 20 mM ascorbate, and 1 mM EDTA, as described in Materials and Methods. (17) and several enzymes from methanogenic archaea (20, 29, 33, 34) . However, modifications of the pterin ring and attached aminobenzene moiety (Fig. 1) , which distinguish methanopterin derivatives from folates, substantially influence DmrA activity. Notably, H 2 F was not a substrate for DmrA at the physiological pH of 6.8 and exhibited only a low level of activity under the optimal in vitro conditions for the enzyme (pH 5.3). In DmrA, the presence of a conserved acidic amino acid (aspartate 35) that is important for pterin binding in DHFRs may contribute to the ability of DmrA to bind and reduce H 2 F at a low rate. Previous genetic evidence supports a role for DmrA in the H 4 MPT-dependent catabolism of C 1 compounds (23) . dmrA mutants grow on succinate but not on C 1 compounds, and the mutants are highly sensitive to methanol toxicity. This phenotype has been observed previously for M. extorquens mutants deficient in two enzymes of the H 4 MPT-dependent pathway, namely, formaldehyde-activating enzyme (38) and methylene-H 4 MPT dehydrogenase B (17) . In addition, the dmrA mutant is incapable of producing dephospho-H 4 MPT, consistent with a deficiency in an enzyme required for dephospho-H 4 MPT biosynthesis (S. A. Wyles and M. E. Rasche, unpublished data). Finally, the genome of M. extorquens contains two additional DHFR analogs which appear to be involved in the reduction of H 2 F to H 4 F (6, 23). These results, combined with the biochemical data presented here, support the proposal that DmrA functions as H 2 MPT reductase, the last proposed enzyme of the H 4 MPT biosynthesis pathway.
Although many bacterial enzymes involved in H 4 MPT-dependent C 1 metabolism are homologous to archaeal enzymes (7) , no archaeal homologs of DmrA have been identified. This is perhaps not surprising if one considers that H 2 MPT reductase from methanogenic archaea is likely to use the methanogen cofactor F 420 H 2 as an electron donor instead of NADPH. A similar phenomenon has been observed previously for the NAD-dependent methylene-H 4 MPT dehydrogenase B (MtdB) of M. extorquens, which also lacks an archaeal homolog but is closely related to an NADP-dependent methylene-tetrahydrofolate dehydrogenase from the same organism (7, 17) . The archaeal version of methylene-H 4 MPT dehydrogenase uses F 420 H 2 as an electron donor (35) and is not closely related in sequence to the bacterial counterpart. In addition, Pomper et al. (26) have reported a third bacterial H 4 MPT-dependent dehydrogenase that deviates from its archaeal counterpart. Transfer of a formyl group from dephospho-H 4 MPT to the coenzyme methanofuran in M. extorquens is catalyzed by a formyltransferase related to an archaeal homolog (26) . However, instead of directly oxidizing the formyl group to CO 2 as predicted by analogy to the archaeal formyltransferase, the bacterial enzyme releases formate without oxidation. Formate is then oxidized by a bacterial NAD-dependent formate dehydrogenase. Based on these three examples, it is anticipated that if additional dehydrogenases are required for H 4 MPT biosynthesis in M. extorquens, the enzymes will be NADPH dependent and homologous to bacterial genes rather than archaeal genes. This may be a general feature of bacterial dehydrogenases evolved for use in metabolic pathways derived from methanogenic archaea.
Characterization of H 4 MPT-dependent enzymes has led to speculation about the evolutionary events resulting in the existence of both H 4 MPT and H 4 F in methylotrophic bacteria. If clusters of archaeal-gene-like C 1 metabolism genes were acquired by horizontal gene transfer, the three dehydrogenases described above may illustrate how host genes can be rapidly adapted to function in new metabolic pathways following interdomain horizontal gene transfer. Archaeal genes encoding proteins dependent on F 420 instead of NAD(P) would have been nonfunctional in M. extorquens, which is not known to synthesize F 420 . To take advantage of the newly acquired genes for H 4 MPT-dependent enzymes, cells would need to develop strategies to replace the F 420 -dependent enzymes. In the case of DmrA and MtdB, M. extorquens appears to have adapted its own folate-dependent enzymes to function in H 4 MPT-dependent metabolism. One possible evolutionary scenario is that the DNA sequence encoding the F 420 binding site of DmrA may have been lost and the remaining portion of the gene spliced with an NADPH-binding sequence through gene duplication and homologous recombination with a bacterial DHFR gene. Alternatively, accumulated mutations or rearrangements involving solely bacterial genes, such as a duplicated DHFR gene, might be sufficient to alter the substrate specificity from H 2 F to H 2 MPT. Identifying specific amino acids that distinguish between the preference of DmrA for H 2 MPT rather than H 2 F may provide insight into the evolutionary processes by which host genes are adapted to accommodate new metabolic pathways following horizontal gene transfer. Characterization of H 2 MPT reductases from archaea and bacteria will provide further insight into the evolutionary relationships among organisms that utilize methanopterin.
